Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for UCSD Molecular COVID-19 Test

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization for a PCR-based SARS-CoV-2 test developed by the University of California, San Diego.

The UCSD EXCITE COVID-19 Test is designed to qualitatively detect SARS-CoV-2 nucleic acid in anterior nasal swab specimens collected either by a healthcare provider or self-collected at home or in a community-based setting. It was developed by the UCSD BCG Expedited Covid Identification Environment (EXCITE) Lab.

Use of the test is limited to the EXCITE Lab, according to the FDA.

According to the authorization letter from the FDA, samples collected from individuals up to 2 years of age should be done with adult assistance. Individuals 15 and older, including those who are asymptomatic, can self-collect samples when deemed appropriate by a healthcare provider.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.